Clinical Trial Update: Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg [Phase 1]

View source ↗

Summary

Phase 1 single-cohort, two-period pharmacokinetic study evaluating metformin alone and in combination with ranolazine (500 mg) in Type 2 Diabetes Mellitus, comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Ranolazine (ranolazine)
• metformin (metformin)

Snippet

Sponsor: Gilead Sciences | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED